Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Enviro and Antin announces final investment decision for plant in Uddevalla

· The joint venture between Scandinavian Enviro Systems (publ) ("Enviro" or the "Company") Michelin and Antin Infrastructure Partners today made the final investment decision regarding the construction of the end of life tire recycling plant in Uddevalla, Sweden. · The joint venture has secured equity financing for the construction of the plant and signed multi-year agreements for the supply of end-of-life tires and offtakes for the recovered carbon black and oil products. The signed agreements regarding deliveries of recovered materials have a total value of approximately MEUR 180 (SEK 2

Completed sale of shares in RevolutionRace

7 February 2024 THIS PRESS RELEASE IS FOR THE USE OF THE INTENDED RECIPIENT ONLY AND SHOULD NOT BE COPIED OR DISTRIBUTED TO ANY OTHER PERSON. NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHOLLY OR PARTLY, IN OR INTO THE U.S. (OR TO U.S. PERSONS) ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER U.S. SECURITIES ACT OF 1933, AS AMENDED, OR IN ANY OTHER JURISDICTION IF SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT

Ambea resolves on repurchase of own shares

The board of directors in Ambea AB (publ) has resolved to repurchase a maximum of 3 000 000 own shares on Nasdaq Stockholm during the period until the time of the company’s Annual General Meeting 2024. The resolution is made by virtue of the authorisation from the Annual General Meeting 2023 to repurchase own shares.The objective of the share repurchase program is to optimise the company’s capital structure and contribute to increased shareholder value.The share repurchase program will be managed by a credit institution that will act in accordance with instructions from the company.

Nordea Bank Abp: Repurchase of own shares on 07.02.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares07.02.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 07.02.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |52,229 |10.81 |564,799.18

Stena RoRo takes delivery of E-Flexer RoPax vessel number ten for long charter to Canadian Crown Corporation Marine Atlantic

Today, number ten of the Stena RoRos E-Flexer series was delivered from the CMI Jinling, Weihai Shipyard. The vessel, named Ala'suinu, will be on a long charter agreement with the Canadian state-owned Marine Atlantic and operate a ferry line in eastern Canada between Newfoundland and Nova Scotia. “We are very excited to welcome the Ala’suinu to our service,” says Gary O'Brien, Chair, Board of Directors, Marine Atlantic.With a focus on reducing our environmental impact, the latest accessibility features, state-of-the-art technologies, and enhanced customer amenities, I am

Intervacc awarded prestigious Eurostars grant to advance their new prototype vaccine against Streptococcus suis infection in pigs

Stockholm, February 7, 2024 - Intervacc AB (publ) announces that it, together with Moredun Scientific, has been awarded a grant from the Eurostars-3 programme covering approx. 50 % of the €1.7 million project to advance Intervacc’s prototype vaccine against Streptococcus suis infections in pigs. Streptococcus suis causes meningitis, septicaemia and arthritis in young piglets, leading to significant costs to the pig industry throughout the world. Intervacc’s innovative vaccine technology utilises fusion proteins to generate broad-acting immune responses that provide protection to animals

MyFirstApp Initiates Collaboration with IR-Partner

Stockholm - February 7, 2024 MyFirstApp has entered into a strategic collaboration agreement with IR-Partner AB. In accordance with the board's prior authorization, the company has decided to compensate the new collaboration partner through a directed offset issue. This decision was made to avoid impacting the company's liquidity. The company has intensified its marketing efforts to directly reach the end-users of its products. Through the partnership with IR-Partner AB, MyFirstApp will be able to enhance its communication with both existing and potential shareholders. As compensation

WntResearch carries out a directed issue of units to underwriters in connection with the completed rights issue

Wntresearch AB (“WntResearch” or the “Company”) has completed the rights issue of units, consisting of shares and warrants series TO 7 and TO 8, resolved upon by the board of directors on 20 November 2023 and subsequently approved by the extraordinary general meeting on 22 December 2023 (the “Rights Issue”). In connection herewith, in accordance with the underwriting commitments that have been entered into and what has been previously communicated, a directed issue of units is carried out to those underwriters in the Rights Issue who have chosen to receive underwriting compensation in the

Eevia Health Plc has secured a credit line of SEK 7.2 million for working capital purposes to finance continued growth

Eevia Health Plc, (”Eevia” or ”The Company”), has entered into an agreement whereby Råsunda Förvaltning AB, Upgrade Invest Nordic AB, and Renewable Ventures Nordic AB will provide a credit line for Eevia of up to SEK 7.2 million (EUR 640,000) giving the Company increased working capital flexibility to finance its continued growth. The term of the Credit line is until June 30, 2024, and it is unsecured. Interest is charged at two (2.0) percent per month and a five (5) percent arrangement fee.Stein Ulve, Chief Executive Officer states: “Eevia had a transformative 2023 where we broadened our

SmartCraft ASA (SMCRT) - Transactions carried out under the share buy-back program

Please see below information about transactions made under the share buy-back programme for SmartCraft ASA (“SmartCraft”) (Ticker: SMCRT NO). Date on which the share buy-back programme was announced: 28 April 2023. The duration of the buy-back programme: 28 April 2023 until no later than the day before the Issuer's Annual General Meeting in 2024. Size of the buy-back programme: Up to 3,430,446 shares, for a maximum consideration of NOK 85,000,000. From 30 January 2024 until 7 February 2024, SmartCraft has purchased a total of 43,584 own shares at an average price of NOK 24.7326

Bactiguard appoints Christine Lind as new CEO

The Board of Directors of Bactiguard Holding AB (publ.) has appointed Christine Lind as new CEO. Christine brings broad strategic and operational experience from more than 25 years in the healthcare sector. Previous assignments encompass positions in Swedish listed companies such as Mendus AB, XSPRAY PHARMA AB, and Medivir AB as well as senior advisory roles. Prior to that, Christine spent a decade as an investment banker at Merrill Lynch. She joins Bactiguard at the beginning of May and assumes the role as CEO on 14 May 2024 in connection with the Annual General Meeting.“We are delighted

Attendo to buy back shares for a maximum amount of SEK 110 million

Attendo’s Board of Directors has decided to utilize the authorization by the 2023 AGM to acquire own shares in order to adjust the company’s capital structure.The share buyback programme will be carried out in accordance with the EU Market Abuse Regulation (MAR) and Commission Delegated Regulation (EU) 2016/1052 (the so-called Safe Harbour Regulation). Acquisitions of shares will be managed by Skandinaviska Enskilda Banken AB.   The share buyback programme is subject to the following terms:   · Buybacks are to take place on Nasdaq Stockholm in accordance with its Rule Book for

Ambea resolves on repurchase of own shares

The board of directors in Ambea AB (publ) has resolved to repurchase a maximum of 3 000 000 own shares on Nasdaq Stockholm during the period until the time of the company’s Annual General Meeting 2024. The resolution is made by virtue of the authorisation from the Annual General Meeting 2023 to repurchase own shares.The objective of the share repurchase program is to optimise the company’s capital structure and contribute to increased shareholder value.The share repurchase program will be managed by a credit institution that will act in accordance with instructions from the company.

Kuva Space appoints Jerry Welsh to spearhead U.S. expansion to establish Kuva Space as the leading hyperspectral insights provider to the U.S. Government

Former ICEYE US CEO Jerry Welsh joins Kuva Space as a board member of its new U.S. entity to drive strategic growth initiatives in the United States.Finnish hyperspectral satellite and AI-powered insights company Kuva Space  has announced its expansion to the United States, establishing Kuva Space US in Fairfax, Virginia. Jerry Welsh, the former CEO of ICEYE US, joins Kuva Space as a board member and will lead the company’s expansion efforts to become a leading provider of hyperspectral insights to the U.S. Government (USG).   With its new U.S. subsidiary, Kuva

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 07 February 2024 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 07 February 2024 it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)

Contemplated sale of shares in RevolutionRace

7 February 2024 THIS PRESS RELEASE IS FOR THE USE OF THE INTENDED RECIPIENT ONLY AND SHOULD NOT BE COPIED OR DISTRIBUTED TO ANY OTHER PERSON. NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHOLLY OR PARTLY, IN OR INTO THE U.S. (OR TO U.S. PERSONS) ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER U.S. SECURITIES ACT OF 1933, AS AMENDED, OR IN ANY OTHER JURISDICTION IF SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT

Giant BidCo publishes a supplement to the offer document for the recommended public cash offer to the shareholders of Byggfakta

THIS PRESS RELEASE IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE AND IN THE

Continued collaboration between Minesto and Swedish Energy Agency - 3 MSEK funding awarded for upgrading of mooring system

The Swedish Energy Agency has awarded Minesto a 2.8 MSEK grant to support development and testing of next generation mooring system. The grant co-funds a project through which Minesto will advance performance of the unique tether system that moors the powerplant to the seabed.Minesto has been awarded funding by the Swedish Energy Agency to continue optimization of tethering solutions to further leverage reliability and performance of this core system.   The funding is part of the CETPartnership (Clean Energy Transition Partnership) program and include collaboration with Swedish, Spanish

The Board of Directors of Carbiotix AB decides on a directed issue to guarantors

The board of directors of Carbiotix AB ("Carbiotix" or the "Company") has today decided, with the support of authorization from the extraordinary general meeting, to carry out a directed issue of units, in accordance with the guarantee agreements entered into between the guarantors and the Company due to the preferential issue which was carried out during January 2024.As previously communicated in connection with the rights issue, the bottom guarantors, in accordance with the guarantee agreements entered into, had the opportunity to choose to receive guarantee compensation in the form of

Invitation to presentation of Lea Bank's results for the 4th quarter of 2023

Lea Bank will present the results for the 4th quarter of 2023 on Thursday, February 15th at 10:00 AM. The presentation will take place at the bank's premises at Holbergs gate 21, Oslo. Additionally, the presentation will be broadcasted via Microsoft Teams. Please RSVP indicating whether you will attend physically or digitally to ir@leabank.no  The Teams link will be sent prior to the presentation. The results will be publicly disclosed on the company's website (www.leabank.no) and Oslo Stock Exchange (www.newsweb.no)  Contact information: Oddbjørn Berentsen, CEO

BioStock: BiBB’s CEO - “European CE approval is a significant milestone”

BiBBInstruments has received CE certification for EndoDrill in Europe in accordance with MDR. The certification is valid for all three variants of the EndoDrill product family - diagnostic tissue sampling in pancreas, lungs and urinary bladder cancer - paving the way for a market launch of the lead product EndoDrill GI in Sweden later this year. EndoDrill has thus become the first electric-driven endoscopic biopsy instrument to be cleared in both the US and Europe in less than a year. BioStock reached out to BiBB’s CEO Fredrik Lindblad for a comment.Read the interview with Fredrik Lindblad

There are no items matching the current filter
There are no more items matching the current filter
Back to top